Future Fertility Inc. is a Canada-based AI med-tech startup specializing in reproductive innovations through advanced image analysis software tools (VIOLET™ & MAGENTA™) that evaluate the reproductive potential of human eggs (oocytes). Their non-invasive AI-powered technology uses a single image of an egg taken from a standard light microscope to provide objective insights into egg quality, aiding personalized patient feedback, tailored treatment plans, and improved IVF outcomes.

Future Fertility's mission is to bring the power of AI to collaborate with fertility professionals, optimize reproductive care, and empower patients at all stages of their fertility journey. Their vision is to unlock the future of personalized fertility care worldwide.

The team comprises experts in data science, machine learning, reproductive endocrinology, embryology, clinical research, and user-experience design. Notable leadership includes CEO Christy Prada, CMO and Co-Founder Dr. Dan Nayot, and CTO and Co-Founder Alex Krivoi, who drive the company’s innovation and growth.

Respect, Ownership, Human focus, Transparency, and Science guide the company’s culture and approach to fertility care innovation.

Future Fertility’s AI-powered assessments are used by over 200 clinics across 30+ countries, enabling personalized fertility treatment decisions. Their tools are clinically validated and backed by scientific research, with presentations at international conferences and numerous published abstracts.

Future Fertility maintains an active presence on LinkedIn to engage with the fertility and reproductive medicine community, sharing updates, research, and career opportunities.